Detall de la convocatòria
Característiques
| Característica |
|---|
|
Objectiu de la convocatòria
The Alzheimer's Drug Discovery Foundation (ADDF) funds drug discovery and development research programs in the field of Alzheimer's disease (AD), related dementias and cognitive aging. The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising drug discovery and development programs. In addition to funding academic programs, the ADDF also invests in and creates early stage biotechnology companies. The ADDF also co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation. |
|
Característiques principals
The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) have launched the Treat Frontotemporal Degeneration (FTD) Fund to support clinical trials testing novel or repurposed drugs for FTD and related disorders (bvFTD, PPA, PSP, CBD, FTD/ALS). The Treat FTD Fund will build on recent successes of both foundations in early-stage drug discovery and biomarker development and leverages new ongoing efforts under development by AFTD such as the recently launched FTD Disorders Registry and a $5M FTD Biomarker Initiative. |
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.: 1670 |
|
Convocatòria (URL)
http://www.alzdiscovery.org/research-and-grants/funding-opportunities |
|
Dotació
Budgets averaging $500,000-$2,000,000. |
|
Durada
1-3 years |
|
AVÍS IMPORTANT
Letter of Intent Deadline: November 15, 2016 Full Application Deadline: February 15, 2017 |
Arxius
| Arxiu |
|---|
| Request For Proposals |